Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

Cao, Yihai
February 2010
Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107
Academic Journal
Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue vasculature. Pharmacological manipulation of adipose tissue neovascularization by angiogenic stimulators and inhibitors might therefore offer a novel therapeutic option for the treatment of obesity and related metabolic disorders. This Perspective discusses recent progress in understanding the molecular mechanisms that control adipose tissue angiogenesis and in defining potential new vascular targets and approaches for the treatment of this group of diseases.


Related Articles

  • Stressed liver and muscle call on adipocytes with FGF21. Yongde Luo; McKeehan, Wallace L. // Frontiers in Endocrinology;Dec2013, Vol. 4, p1 

    Fibroblast growth factor 21 (FGF21) is an emerging regulator of local and systemic metabolic homeostasis. Treatment with pharmacological levels of FGF21 alleviates obesity and associated metabolic diseases including diabetes. However, beyond anti-obesogenic effects, the normal roles and...

  • Evidence against a Beneficial Effect of Irisin in Humans. Raschke, Silja; Elsen, Manuela; Gassenhuber, Hans; Sommerfeld, Mark; Schwahn, Uwe; Brockmann, Barbara; Jung, Raphael; Wisløff, Ulrik; Tjønna, Arnt E.; Raastad, Truls; Hallén, Jostein; Norheim, Frode; Drevon, Christian A.; Romacho, Tania; Eckardt, Kristin; Eckel, Juergen // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Brown adipose tissue has gained interest as a potential target to treat obesity and metabolic diseases. Irisin is a newly identified hormone secreted from skeletal muscle enhancing browning of white fat cells, which improves systemic metabolism by increasing energy expenditure in mice. The...

  • Filling the Void. Vash, Peter // JAMA: Journal of the American Medical Association;4/4/2012, Vol. 307 Issue 13, p1381 

    A personal narrative is presented which explores the author's experience of treating Paula's obesity who weighed more than 325 pounds.

  • Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Liu, Jian; Divoux, Adeline; Sun, Jiusong; Zhang, Jie; Clément, Karine; Glickman, Jonathan N.; Sukhova, Galina K.; Wolters, Paul J.; Du, Juan; Gorgun, Cem Z.; Doria, Alessandro; Libby, Peter; Blumberg, Richard S.; Kahn, Barbara B.; Hotamisligil, Gökhan S.; Shi, Guo-Ping // Nature Medicine;Aug2009, Vol. 15 Issue 8, p940 

    Although mast cell functions have classically been related to allergic responses, recent studies indicate that these cells contribute to other common diseases such as multiple sclerosis, rheumatoid arthritis, atherosclerosis, aortic aneurysm and cancer. This study presents evidence that mast...

  • Editorial: Control of adipocyte differentiation and metabolism. Capilla, Encarnación; Navarro, Isabel // Frontiers in Endocrinology;Aug2015, p1 

    The article discusses the various studies to control adipose tissue's differentiation, adipokines production, and metabolism as a therapeutic use in treating obesity.

  • Scientists discover switch that turns white fat brown.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p168 

    The article reports on the discovered biological switch by scientists that gives energy-storing white fat the characteristics of energy-burning brown fat that may lead to the development of strategies for treating obesity.

  • Nature Medicine: A new candidate pathway for treating visceral obesity.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article focuses on a research led by researchers of the Brigham and Women's Hospital, Boston, Massachusetts, who has developed white fat with the characteristics of brown fat in bodies to treat visceral obesity.

  • The different shades of fat. Peirce, Vivian; Carobbio, Stefania; Vidal-Puig, Antonio // Nature;6/1/2014, Vol. 510 Issue 7503, p76 

    Our understanding of adipose tissue biology has progressed rapidly since the turn of the century. White adipose tissue has emerged as a key determinant of healthy metabolism and metabolic dysfunction. This realization is paralleled only by the confirmation that adult humans have heat-dissipating...

  • POHYBOVÁ INTERVENCE JAKOU SOUČÁST LÉČENÍ NADVÁHY A OBEZITY. Poděbradská, R. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;Aug2011, Vol. 18 Issue 2, p50 

    This article contains new aspects of obesity as a disease and an insight into physical activity in treating obesity. Currently, obesity is the most frequent metabolic disease (9) and it is important to search for a common, effective application for its prevention and treatment. Ideally, for a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics